Mechanism of advanced glycation end products inhibiting the proliferation of peripheral blood mononuclear cells and osteoblasts in rats

  • Zheng LI ,
  • Xiao WANG ,
  • Tian-pei HONG ,
  • Hao-jie WANG ,
  • Zhan-yi GAO ,
  • Meng WAN
Expand
  • 1. Department of Stomatology, Peking University Third Hospital, Beijing 100191, China
    2. Department of Endocrinology, Peking University Third Hospital, Beijing 100191, China

Received date: 2019-09-16

  Online published: 2021-04-21

Supported by

Special Fund for the Study of the Relationship between Oral Diseases and Systemic Diseases of the Chinese Stomatological Association(CSA-Y2015-08)

Abstract

Objective: To explore the mechanism of nuclear factor-kappa B (NF-κB), phosphatidylinositol 3-kinase (PI3K)/protein kinase B(PKB/Akt) and mitogen-activated protein kinase (MAPK) signaling pathways after intervention of advanced glycosylation end products (AGEs) in peripheral blood mononuclear cells (PBMCs) and osteoblasts (OB) in rats, so as to provide certain experimental basis and theoretical basis for further research on the clinical treatment of periodontal tissue inflammation caused by diabetes mellitus. Methods: AGEs were prepared, PBMCs and OB were isolated and cultured in vitro. CCK-8 was used to detect the cell viability intervened by different concentrations and time of AGEs. Western blot and qRT-PCR were used to detect the expression changes of genes related to NF-κB, PI3K/PKB and MAPK signaling pathways. Results: OB and PBMCs were successfully isolated and cultured in vitro. The activity of PBMCs and OB cells was significantly correlated with the concentration, time and interaction of AGEs. With the increase of AGEs concentration and time, the activity of PBMCs and OB cells significantly decreased (P<0.001). AGEs stimulation significantly increased the expression of NF-κB in PBMCs and the contents of tumor necrosis factor α(TNF-α), interleukin-1β(IL-1β) (P<0.01). TNF-α, IL-1β levels were significantly reduced after inhibition of NF-κB pathway (P<0.01). NF-κB p65, JNK, and p38 phosphorylated and non-phosphorylated proteins increased significantly after AGEs stimulation of OB (P<0.05). The phosphorylated protein expression of IκB was significantly increased, while the expression of non-phosphorylated protein was decreased (P<0.01).The expressions of NF-κB p65, JNK, and IκB were significantly increased at the mRNA levels, and the expressions of IκB mRNA were significantly decreased (P<0.05). There was no difference in the expression of Akt in either phosphorylated or non-phosphorylated proteins or at the mRNA level (P>0.05). With the addition of MAPK signaling pathway inhibitors, the phosphorylation and non-phosphorylated protein expressions of NF-κB p65, p38 and JNK were significantly reduced, and the phosphorylated protein of IκB was significantly decreased and the non-phosphorylated protein was significantly increased compared with the group with AGEs alone (P<0.05). The results of qRT-PCR showed that the expression of IκB increased significantly after the addition of the JNK pathway blocker (P<0.05), and the expression of NF-κB p65, p38 and JNK decreased, but the difference was not significant (P>0.05). While NF-κB p65, p38 and JNK were significantly decreased and IκB was significantly increased in the AGEs group after the addition of the p38 pathway blocker (P<0.05). At this time, there was still no significant change in the expression of Akt at the protein level and mRNA level (P>0.05). Conclusion: AGEs inhibit the proliferation of PBMCs and OB, and the NF-κB and MAPK pathways are likely involved in regulating this process, but not the PI3K/PKB pathway.

Cite this article

Zheng LI , Xiao WANG , Tian-pei HONG , Hao-jie WANG , Zhan-yi GAO , Meng WAN . Mechanism of advanced glycation end products inhibiting the proliferation of peripheral blood mononuclear cells and osteoblasts in rats[J]. Journal of Peking University(Health Sciences), 2021 , 53(2) : 355 -363 . DOI: 10.19723/j.issn.1671-167X.2021.02.021

References

[1] Petersen PE, Ogawa H. The global burden of periodontal disease: Towards integration with chronic disease prevention and control[J]. Periodontol 2000, 2012,60(1):15-39.
[2] 李峥, 沙月琴, 张博学, 等. 参加社区慢性病管理的糖尿病患者牙周健康状况调查及相关因素分析[J]. 中华口腔医学杂志, 2007: 42(2):100-101.
[3] Papapanou PN. Periodontal disease: Epidemiology[J]. Annals of Periodontol, 1996,1(1):11-36.
[4] Khader YS, Dauod AS, El-Qaderi SS, et al. Periodontal status of diabetics compared with nondiabetics: A meta-analysis[J]. J Diabetes Complications, 2006,20(1):59-68.
[5] Taylor JJ, Preshaw PM, Lalla E. A review of the evidence for pathogenic mechanisms that may link periodontitis and diabetes[J]. J Periodontol, 2013,84(4 Suppl.):S113-S134.
[6] Taiyeb-Ali TB, Cheta Raman RP, Vaithilingam RD. Relationship between periodontal disease and diabetes mellitus: An Asian perspective[J]. Periodontol 2000, 2011,56(1):258-268.
[7] Ulrich P, Cerami A. Protein glycation, diabetes, and aging[J]. Recent Prog Horm Res, 2001,56(1):1-21.
[8] Ramasamy R, Vannucci SJ, Yan SS, et al. Advanced glycation end products and RAGE: A common thread in aging, diabetes, neurodegeneration, and inflammation[J]. Glycobiology, 2005,15(7):16R-28R.
[9] Neeper M, Schmidt AM, Brett J, et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins[J]. J Biol Chem, 1992,267(21):14998-15004.
[10] Southerlan JH, Taylor GW, Moss K, et al. Commonality in chro-nic inflammatory diseases: Periodontitis, diabetes, and coronary artery disease[J]. Periodontol 2000, 2006,40(1):130-143.
[11] Lin L. RAGE on the Toll Road?[J]. Cell Mol Immunol, 2006,3(5):351-358.
[12] Schmidt A, Yan S, Brett J, et al. Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products[J]. J Clin Invest, 1993,91(5):2155-2168.
[13] Anfelika B, Stephan S, Markus S, et al. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappa B[J]. Diabetes, 2001,50(12):2792-2808.
[14] Chen Q, Dong L, Wang L, et al. Advanced glycation end pro-ducts impair function of late endothelial progenitor cells through effects on protein kinase Akt and cyclooxygenase-2[J]. Biochem Biophys Res Commun, 2009,381(2):192-197.
Outlines

/